Use of botulinum toxin in blepharospasm and other facial spasms
- 1 June 1987
- journal article
- Published by Wiley in Acta Ophthalmologica
- Vol. 65 (3) , 313-319
- https://doi.org/10.1111/j.1755-3768.1987.tb08512.x
Abstract
Essential blepharospasm is an involuntary spasmodic closure of the eyelids. It frequently makes normal social human life such as reading, driving and even walking almost impossible. Botulinum toxin has been approved for investigational use for treatment of blepharospasm. We report the results and side‐effects of botulinum A toxin treatment of the first 13 patients in Finland. Temporary control of spasms was achieved in all patients varying from 1 to 38 weeks with a mean of 11 weeks after the first injection. Most patients needed re‐treatment after varying intervals. All complications were transient.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of Facial Spasm with Botulinum ToxinOphthalmology, 1986
- The Use of Botulinum Toxin in BlepharospasmAmerican Journal of Ophthalmology, 1985
- Botulinum A Toxin Injection as a Treatment for BlepharospasmArchives of Ophthalmology (1950), 1985
- Management of BlepharospasmOphthalmic Plastic & Reconstructive Surgery, 1985
- Treatment of Blepharospasm With Botulinum ToxinArchives of Ophthalmology (1950), 1984
- Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patientsAnnals of Neurology, 1983